The global veterinary point of care diagnostics market size surpassed USD 1,992 million in 2024 and is predicted to reach around USD 5,261 million by 2034, registering a CAGR of 10.2% from 2025 to 2034.
The veterinary point of care diagnostics market encompasses a broad portfolio of testing services in the field of veterinary medicine. Rather than in centralized laboratories, these services are performed at or near the site where animals receive care. The pet healthcare industry industry has seen a significant growth with rising adoption of exotic pets that require regular health checks. Moreover, with rising awareness of animal rights and growing healthcare expenditure, research on diagnostics has become more sophisticated. This resuled in several products entering thr trial phases.
The veterinary point of care diagnostics market necessary to provide prompt treatment, rapid diagnostics, and animal health management. The market is further driven by strategic business ventures in the form of investments, mergers, and acquisitions. One such example is the USD 4 million Series A funding secured by MI:RNA, Scottish veterinary diagnostics company. MI:RNA seeks to use revolutionary biomarker technology and artificial intelligence to improve health outcomes for animals through earlier disease diagnosis.